+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Immunoglobulins, binding opioid peptides, biogenic amines, and opiates, in substance abusers



Immunoglobulins, binding opioid peptides, biogenic amines, and opiates, in substance abusers



Sudebno-Meditsinskaia Ekspertiza 44(1): 18-20



Immunoglobulins binding morphine, biogenic amines, and an opioid peptide dermorphine were measured by solid-phase enzyme immunoassay in patients abusing narcotics. The patients' ages varied from 20 to 40, with the duration of narcotic use 1-17 years. Narcotic dependence was found to involve increased production of immunoglobulins binding opioid and monoamine neuromediators. Enzyme immunoassay of antibodies to opiates detects latent forms of narcomania in cases when the narcotic is not present in the body. These results serve the basis for creating a new method for analysis of narcotic abuse and evaluation of the duration of their use, which can be used in practical medicine and in forensic medical expert evaluations.

(PDF emailed within 1 workday: $29.90)

Accession: 046333415

Download citation: RISBibTeXText

PMID: 11255956


Related references

Immunoglobulins binding opioid peptides, biogenic amines, and opiates in narcomaniacs. Sudebno-Meditsinskaya Ekspertiza 44(1): 18-20, January-February, 2001

Immunoglobulin-binding biogenic amines in substance abusers. Immunologiya 0(3): 45-47, 1992

Comparison of the binding characteristics of tritiated opiates and opioid peptides. British Journal of Pharmacology 66(1): 86p-87p, 1979

Comparison of the binding characteristics of tritiated opiates and opioid peptides. British Journal of Pharmacology 70(3): 481-490, 1980

Opiate receptor binding affected differentially by opiates and opioid peptides. European Journal of Pharmacology 55(1): 11-18, 1979

Binding of opiates and endogenous opioid peptides to neuroleptic receptor sites in the corpus striatum. Life Sciences 22(11): 953-962, 1978

Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. Molecular Pharmacology 16(1): 91-104, 1979

CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin). Biological Psychiatry 39(11): 911-918, 1996

CSF of untreated neuroleptic-naive-first episode schizophrenic patients Level of biogenic amines, substance P and peptides derived from chromogranin A and secretogranin II. Pharmacopsychiatry 28(5): 203, 1995

Immunoglobulins binding opioid peptides in patients with atopic dermatitis and opium addiction. Immunologiya (2): 42-44, 1991

A brief history of opiates, opioid peptides, and opioid receptors. Proceedings of the National Academy of Sciences of the United States of America 90(12): 5391-5393, 1993

Psychoactive substance use prior to the development of iatrogenic opioid abuse: A descriptive analysis of treatment-seeking opioid abusers. Addictive Behaviors 65: 242-244, 2016

Opiates, opioid peptides and psychiatry. Annals of the New York Academy of Sciences 362: 67-75, 1981

Opiates, opioid peptides, and their receptors. Journal of Cardiothoracic Anesthesia 1(6): 569-576, 1987

The endocrinology of the opiates and opioid peptides. Metabolism: Clinical and Experimental 30(2): 195-209, 1981